In 2016-2020 period Russia's market for musculoskeletal drugs is expected to grow twice faster than the market for the same in the UK.
Between 2016 and 2020 the Russian market for the drugs that treat diseases such as arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome and muscular dystrophy will grow at twice the speed of the next fastest European country, the UK, at nearly 15% against 7% year on year. This will bring th...
